{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:59:05Z","timestamp":1777611545989,"version":"3.51.4"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T00:00:00Z","timestamp":1444953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0140585","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T18:22:31Z","timestamp":1445019751000},"page":"e0140585","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release"],"prefix":"10.1371","volume":"10","author":[{"given":"Yuki","family":"Ishii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May Keu","family":"Nhiayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edison","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Massimino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald L.","family":"Durden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Vigneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Y. J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,10,16]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.6004\/jnccn.2013.0157","article-title":"Chronic Myelogenous Leukemia, Version 1.2014","volume":"11","author":"S O'Brien","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccr.2014.07.006","article-title":"BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia","volume":"26","author":"MS Zabriskie","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/imr.12234","article-title":"Do we need more drugs for chronic myeloid leukemia?","volume":"263","author":"TL Holyoake","year":"2015","journal-title":"Immunol Rev"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/2159-8290.CD-13-0235","article-title":"MEK-dependent negative feedback underlies BCR-ABL-mediated oncogene addiction","volume":"4","author":"J Asmussen","year":"2014","journal-title":"Cancer Discov"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1158\/1535-7163.MCT-09-0685","article-title":"Bim-targeted cancer therapy: a link between drug action and underlying molecular changes","volume":"8","author":"T Akiyama","year":"2009","journal-title":"Mol Cancer Ther"},{"issue":"6747","key":"ref6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/23730","article-title":"Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis","volume":"400","author":"XM Yin","year":"1999","journal-title":"Nature"},{"issue":"5445","key":"ref7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","article-title":"Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity","volume":"286","author":"P Bouillet","year":"1999","journal-title":"Science"},{"issue":"Pt 16","key":"ref8","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1242\/jcs.038166","article-title":"Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis","volume":"122","author":"G Dewson","year":"2009","journal-title":"J Cell Sci"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"RJ Youle","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"18","key":"ref10","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/emboj.2011.307","article-title":"Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases","volume":"30","author":"A Strasser","year":"2011","journal-title":"Embo J"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"e1001394","DOI":"10.1371\/journal.pbio.1001394","article-title":"Bax activation initiates the assembly of a multimeric catalyst that facilitates Bax pore formation in mitochondrial outer membranes","volume":"10","author":"Y Kushnareva","year":"2012","journal-title":"PLoS Biol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2012.08.038","article-title":"Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML","volume":"151","author":"TT Vo","year":"2012","journal-title":"Cell"},{"key":"ref13","first-page":"1","article-title":"Update on emerging treatments for chronic myeloid leukemia","volume":"2015","author":"C Fava","journal-title":"Expert Opin Emerg Drugs"},{"issue":"4 Suppl 1","key":"ref14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.exphem.2007.01.023","article-title":"Optimizing therapy of chronic myeloid leukemia","volume":"35","author":"MW Deininger","year":"2007","journal-title":"Exp Hematol"},{"issue":"23","key":"ref15","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"BJ Druker","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.gde.2005.11.002","article-title":"Targeted CML therapy: controlling drug resistance, seeking cure","volume":"16","author":"T O'Hare","year":"2006","journal-title":"Curr Opin Genet Dev"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4161\/cc.8.9.8209","article-title":"The CML stem cell: evolution of the progenitor","volume":"8","author":"SA Stuart","year":"2009","journal-title":"Cell Cycle"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"AS Corbin","year":"2011","journal-title":"J Clin Invest"},{"key":"ref19","article-title":"Leukemia stem cells: the root of chronic myeloid leukemia","author":"H Zhou","year":"2015","journal-title":"Protein Cell"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/stem.1678","article-title":"Concise review: cancer cells escape from oncogene addiction: understanding the mechanisms behind treatment failure for more effective targeting","volume":"32","author":"F Pellicano","year":"2014","journal-title":"Stem Cells"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"A Hamilton","year":"2012","journal-title":"Blood"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","article-title":"beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia","volume":"23","author":"Y Hu","year":"2009","journal-title":"Leukemia"},{"issue":"7281","key":"ref23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"K Naka","year":"2010","journal-title":"Nature"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1084\/jem.20110304","article-title":"BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia","volume":"208","author":"C Hurtz","year":"2011","journal-title":"J Exp Med"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ccr.2010.04.025","article-title":"Wnt\/Ca2+\/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl","volume":"18","author":"MA Gregory","year":"2010","journal-title":"Cancer Cell"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance","volume":"96","author":"FX Mahon","year":"2000","journal-title":"Blood"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/leu.2014.245","article-title":"Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia","volume":"29","author":"AM Eiring","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/0008-5472.CAN-07-2879","article-title":"Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3","volume":"68","author":"Y Ishii","year":"2008","journal-title":"Cancer Res"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1128\/MCB.26.9.3505-3513.2006","article-title":"Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1","volume":"26","author":"L Zheng","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.molcel.2009.09.030","article-title":"Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis","volume":"36","author":"H Kim","year":"2009","journal-title":"Mol Cell"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ncb1499","article-title":"Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies","volume":"8","author":"H Kim","year":"2006","journal-title":"Nat Cell Biol"},{"issue":"44","key":"ref32","doi-asserted-by":"crossref","first-page":"41604","DOI":"10.1074\/jbc.M207516200","article-title":"Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL","volume":"277","author":"H Yamaguchi","year":"2002","journal-title":"J Biol Chem"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1182\/blood-2006-08-040022","article-title":"Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR\/ABL+ progenitors via JAK-2\/STAT-5 pathway activation","volume":"109","author":"Y Wang","year":"2007","journal-title":"Blood"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/leu.2009.299","article-title":"Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitors","volume":"24","author":"DK Hiwase","year":"2010","journal-title":"Leukemia"},{"issue":"13","key":"ref35","first-page":"970","article-title":"Erythropoietin promotes resistance against the Abl tyrosine kinase inhibitor imatinib (STI571) in K562 human leukemia cells","volume":"1","author":"KM Kirschner","year":"2003","journal-title":"Mol Cancer Res"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0145-2126(90)90002-Q","article-title":"Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts","volume":"14","author":"R Alitalo","year":"1990","journal-title":"Leuk Res"},{"issue":"1","key":"ref37","first-page":"72","article-title":"K562\u2014a human leukemia cell line with erythroid features","volume":"18","author":"CG Gahmberg","year":"1981","journal-title":"Semin Hematol"},{"issue":"5702","key":"ref38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/278364a0","article-title":"Induction of erythroid differentiation in the human leukaemia cell line K562","volume":"278","author":"LC Andersson","year":"1979","journal-title":"Nature"},{"issue":"2","key":"ref39","first-page":"73","article-title":"Induction of megakaryocytic characteristics in human leukemic cell line K562: polyploidy, inducers, and secretion of mitogenic activity","volume":"1","author":"JF Leary","year":"1987","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/blood.V75.1.96.96","article-title":"Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta","volume":"75","author":"JD Cashman","year":"1990","journal-title":"Blood"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1158\/0008-5472.226.65.1","article-title":"Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer","volume":"65","author":"J Amann","year":"2005","journal-title":"Cancer Res"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","article-title":"JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis","volume":"18","author":"LS Steelman","year":"2004","journal-title":"Leukemia"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4161\/cbt.6.6.4101","article-title":"Imatinib and nilotinib induce apoptosis of chronic myeloid leukemia cells through a Bim-dependant pathway modulated by cytokines","volume":"6","author":"F Belloc","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1038\/cddis.2012.111","article-title":"Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence","volume":"3","author":"C Drullion","year":"2012","journal-title":"Cell Death Dis"},{"issue":"8","key":"ref45","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10495-014-0997-9","article-title":"H2AX phosphorylation regulated by p38 is involved in Bim expression and apoptosis in chronic myelogenous leukemia cells induced by imatinib","volume":"19","author":"Y Dong","year":"2014","journal-title":"Apoptosis"},{"issue":"40","key":"ref46","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0606176103","article-title":"Bim and Bad mediate imatinib-induced killing of Bcr\/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic","volume":"103","author":"J Kuroda","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"crossref","DOI":"10.1002\/0471142956.cy0904s14","article-title":"Analysis of intracellular organelles by flow cytometry or microscopy","author":"M Poot","year":"2001","journal-title":"Curr Protoc Cytom"},{"issue":"12","key":"ref48","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.freeradbiomed.2010.09.021","article-title":"Menadione triggers cell death through ROS-dependent mechanisms involving PARP activation without requiring apoptosis","volume":"49","author":"G Loor","year":"2010","journal-title":"Free Radic Biol Med"},{"issue":"14","key":"ref49","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/sj.onc.1210833","article-title":"Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway","volume":"27","author":"MA Gallego","year":"2008","journal-title":"Oncogene"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1038\/cddis.2011.96","article-title":"Hydrogen peroxide: a Jekyll and Hyde signalling molecule","volume":"2","author":"DR Gough","year":"2011","journal-title":"Cell Death Dis"},{"issue":"35","key":"ref51","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1200\/JCO.2011.35.5263","article-title":"First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors","volume":"29","author":"TA Yap","year":"2011","journal-title":"J Clin Oncol"},{"issue":"7","key":"ref52","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1535-7163.MCT-09-1012","article-title":"MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo","volume":"9","author":"H Hirai","year":"2010","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/leu.2012.136","article-title":"Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia","volume":"26","author":"C Simioni","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00280-010-1486-7","article-title":"The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention","volume":"68","author":"SK Peirce","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-07-0669","article-title":"A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity","volume":"68","author":"JR Garlich","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"ref56","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1541-7786.MCR-13-0682","article-title":"A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1alpha and HIF2alpha stability and tumor growth, angiogenesis, and metastasis","volume":"12","author":"S Joshi","year":"2014","journal-title":"Mol Cancer Res"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/jm301522m","article-title":"Synthesis and cancer stem cell-based activity of substituted 5-morpholino-7H-thieno[3,2-b]pyran-7-ones designed as next generation PI3K inhibitors","volume":"56","author":"GA Morales","year":"2013","journal-title":"J Med Chem"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1124\/mol.104.010504","article-title":"Redox regulation of PTEN by S-nitrosothiols","volume":"68","author":"CX Yu","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","article-title":"Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling","volume":"24","author":"PD Ray","year":"2012","journal-title":"Cell Signal"},{"issue":"12","key":"ref60","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/1947601911407325","article-title":"PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control","volume":"1","author":"MM Georgescu","year":"2010","journal-title":"Genes Cancer"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.molmed.2009.03.005","article-title":"The PI3K-PTEN tug-of-war, oxidative stress and retinal degeneration","volume":"15","author":"KH Kang","year":"2009","journal-title":"Trends Mol Med"},{"issue":"21","key":"ref62","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1016\/j.febslet.2009.10.013","article-title":"Radioprotection by short-term oxidative preconditioning: role of manganese superoxide dismutase","volume":"583","author":"NA Belikova","year":"2009","journal-title":"FEBS Lett"},{"issue":"8","key":"ref63","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/ars.2007.1957","article-title":"Redox regulation of cell survival","volume":"10","author":"D Trachootham","year":"2008","journal-title":"Antioxid Redox Signal"},{"issue":"16","key":"ref64","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1101\/gad.14.16.2060","article-title":"tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c","volume":"14","author":"MC Wei","year":"2000","journal-title":"Genes Dev"},{"issue":"5517","key":"ref65","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.1059108","article-title":"Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death","volume":"292","author":"MC Wei","year":"2001","journal-title":"Science"},{"issue":"7216","key":"ref66","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nature07396","article-title":"BAX activation is initiated at a novel interaction site","volume":"455","author":"E Gavathiotis","year":"2008","journal-title":"Nature"},{"issue":"14","key":"ref67","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/sj.onc.1208421","article-title":"Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells","volume":"24","author":"A Essafi","year":"2005","journal-title":"Oncogene"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/156800910791054158","article-title":"Understanding FOXO, new views on old transcription factors","volume":"10","author":"F Zanella","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"ref69","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1083\/jcb.200303026","article-title":"FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons","volume":"162","author":"J Gilley","year":"2003","journal-title":"J Cell Biol"},{"issue":"21","key":"ref70","doi-asserted-by":"crossref","first-page":"18811","DOI":"10.1074\/jbc.M301010200","article-title":"Activation of the ERK1\/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim","volume":"278","author":"R Ley","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cgt.2012.84","article-title":"A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia","volume":"20","author":"LN Zhang","year":"2013","journal-title":"Cancer Gene Ther"},{"issue":"9","key":"ref72","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmed.2006.07.007","article-title":"DNA damage-induced cell death by apoptosis","volume":"12","author":"WP Roos","year":"2006","journal-title":"Trends Mol Med"},{"issue":"4","key":"ref73","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bbamcr.2011.01.026","article-title":"Caspase-8 and bid: caught in the act between death receptors and mitochondria","volume":"1813","author":"C Kantari","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 1","key":"ref74","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1038\/onc.2009.47","article-title":"Bid: a Bax-like BH3 protein","volume":"27","author":"LP Billen","year":"2008","journal-title":"Oncogene"},{"issue":"6","key":"ref75","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.molcel.2013.08.048","article-title":"BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response","volume":"51","author":"KA Sarosiek","year":"2013","journal-title":"Mol Cell"},{"issue":"3","key":"ref76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1097-2765(00)80456-6","article-title":"The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex","volume":"3","author":"H Puthalakath","year":"1999","journal-title":"Mol Cell"},{"issue":"1","key":"ref77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cell.2006.06.025","article-title":"OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion","volume":"126","author":"C Frezza","year":"2006","journal-title":"Cell"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0140585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T12:20:45Z","timestamp":1692102045000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0140585"}},"subtitle":[],"editor":[{"given":"Andreas","family":"Villunger","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,16]]},"references-count":77,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0140585","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,16]]}}}